Victory Capital Management’s Neuronetics STIM Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2020
Q2
– Sell
-6,244
Closed -$12K – 3201
2020
Q1
$12K Buy
6,244
+2,248
+56% +$7.03K ﹤0.01% 3024
2019
Q4
$18K Sell
3,996
-1,747
-30% -$10.9K ﹤0.01% 2617
2019
Q3
$48K Buy
5,743
+1,747
+44% +$19.1K ﹤0.01% 2706
2019
Q2
$50K Hold
3,996
– – ﹤0.01% 1731
2019
Q1
$61K Hold
3,996
– – ﹤0.01% 1695
2018
Q4
$77K Hold
3,996
– – ﹤0.01% 1661
2018
Q3
$128K Sell
3,996
-1,004
-20% -$30.5K ﹤0.01% 1646
2018
Q2
$133K Buy
+5,000
New +$136K ﹤0.01% 1684

Other funds holding STIM

Victory Capital Management's STIM Position: Q2 2020 in Review

Victory Capital Management sold out of Neuronetics (STIM) in Q2 2020, closing a stake of 6,244 shares — an estimated $12K sold.

Victory Capital Management first reported a position in STIM in Q2 2018 and held it in 8 quarters. The position peaked at $133K in Q2 2018. 55 funds tracked by Wall St. Rank hold STIM as of Q2 2020.

  • Victory Capital Management reported no remaining Neuronetics position as of Q2 2020 after selling out during the quarter.
  • Victory Capital Management sold 6,244 Neuronetics shares in Q2 2020, an estimated $12K.
  • Victory Capital Management first reported a position in Neuronetics in Q2 2018 and held it in 8 quarters.
  • Victory Capital Management's Neuronetics position peaked at $133K in Q2 2018.
  • 55 funds tracked by Wall St. Rank held Neuronetics as of Q2 2020.

Based on Victory Capital Management's 13F filing for Q2 2020, filed 7 Aug 2020.